The sugars that pass through rather than feed the baby
Human milk oligosaccharides, or HMOs, are complex sugars made in the breast. Unlike lactose, the main sugar in milk, most HMOs resist digestion in an infant’s small intestine. They travel onward to the colon, where some gut microbes can use them as food.
That makes HMOs a striking example of nutrition working indirectly: a component of milk can benefit an infant by shaping which microbes thrive in the gut, rather than by supplying the baby with calories directly.
A selective advantage for helpful microbes
Some strains of Bifidobacterium—including B. infantis—have enzymes that let them break down HMOs. When these bacteria are present, HMOs can help them grow and compete for space and nutrients with other microbes. The sugars can also act as decoys: some pathogens bind to HMOs instead of attaching to the gut lining, making it harder for them to establish themselves.
The effect depends on which microbes an infant acquires and what they can consume. HMOs are a varied family of molecules, and different microbes use different members of it; they are not a custom-made meal for one bacterium alone.
Early microbes help shape immune development
Gut microbes interact with the developing immune system. Their signals help immune cells learn to distinguish harmless encounters from potential threats, while the gut lining and other defenses continue to mature. This is a gradual process, not an immune system built from scratch by one bacterial species.
Birth can help transfer microbes from parent to infant, but it is only one part of how an infant’s microbial community forms. The memorable twist is that milk supplies food the baby cannot digest precisely because some of its benefits arise after that food reaches the microbes living in the baby’s gut.
